NMTC News and Press, NeuroOne Medical Technologies Corporation From 12/14/22

Palm Beach, FL – December 14, 2022 – FinancialNewsMedia.com News Commentary – A cardiac arrhythmia is an irregular heartbeat caused by incorrect electrical signals that govern the beats of the heart. The improper signaling pathway causes the heart to beat too rapi...

NeuroOne® to Report Fourth Quarter and Fiscal Year 2022 Financial Results and Provide Corporate Update on December 13 PR Newswire EDEN PRAIRIE, Minn. , Dec. 8, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "...

NeuroOne® Successfully Completes Feasibility Study with its OneRF™ Ablation System PR Newswire Animal study completed under the guidance of Dr. Jamie Van Gompel at the Mayo Clinic in Rochester, MN Company on track to submit OneRF 510(k) application ...

NeuroOne® Ships Initial Zimmer Biomet Order for its Evo® sEEG System for Less than 30 Day Use PR Newswire Company focused on manufacturing and commercialization in partnership with Zimmer Biomet EDEN PRAIRIE, Minn. , Nov. 30, 2022 /PRNewswire/ -...

NeuroOne® to Ring Nasdaq Stock Market Closing Bell on November 22 PR Newswire Ceremony to commemorate recent FDA clearance milestone for Company's Evo® sEEG Electrode technology EDEN PRAIRIE, Minn. , Nov. 22, 2022 /PRNewswire/ -- Neu...

Penny stocks are shares of companies trading for less than $5, which makes them excellent targets for day traders. Their lower price also makes them ideal for some investors to want to leap at potentially grassroots opportunities. While the latter is few and far between, the former is somet...

NeuroOne® CEO Dave Rosa Featured on Fox Business Network's 'Mornings with Maria' PR Newswire EDEN PRAIRIE, Minn. , Nov. 21, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technol...

NeuroOne® Receives FDA 510(k) Clearance to Market its Evo® sEEG System for Less than 30 Day Use PR Newswire Company focused on manufacturing ramp for commercialization in partnership with Zimmer Biomet EDEN PRAIRIE, Minn. , Oct. 25, 2022 ...

NeuroOne Medical Technologies Corporation (NMTC) Q3 2022 Earnings Conference Call August 11, 2022 5:30 PM ET Company Participants Dave Rosa - President and Chief Executive Officer Ron McClurg - Chief Financial Officer Conference Call Participants Alexande...

NeuroOne Medical Technologies Corporation press release ( NASDAQ: NMTC ): Q3 Net Loss of $2.8M Product revenue of $0.03M As of June 30, 2022, the Company had cash of approximately $10.2 million, compared to $6.9 million as of September 30, 2021, the end of the Company'...